FAQs - Macromolecular Crystallography
Frequently Asked Questions on the Macromolecular Crystallography beamlines (MX1 and MX2)
Showing 201 - 220 of 772 results
Frequently Asked Questions on the Macromolecular Crystallography beamlines (MX1 and MX2)
Industrial Engagement Manager at ANSTO and Professor in Advanced Structural Materials at the University of Sydney, Anna Paradowska is among the authors who contributed to a 2019 paper that was recently awarded the ASM International ASM Henry Marion Howe Medal in Metallurgical and Materials Transactions A.
ANSTO has a full suite of mineralogical, chemical and hydrometallurgical facilities from laboratory through to pilot scale.
ANSTO's Minerals team provides consultancy, process development and research services to the mining and minerals processing industries.
Three new federal grants were announced to support manufacturing and nuclear technologies.
When an energetic ion beam hits a sample it will interact with the atoms through a number of very complex interactions. By detecting and measuring the reaction products resulting from the various interactions and their intensities, you can obtain quantitative data on the sample's constituent elements and their spatial distribution.
Technology for enclosed spaces recently won global COVID19 NASA hackathon
PNG Fisheries expresses great satisfaction with the progress of aquaculture initiative.
With more than 50 years of experience in monitoring natural and anthropogenic radionuclides in the environment, ANSTO can provide the crucial data and insights you need to assist with the planning and risk management associated with oil and gas decommissioning.
Australia and Sri Lanka develop action plan to fight Chronic Kidney Disease killer
Radiocarbon dating at ANSTO’s Centre for Accelerator Science provided strong evidence that some culturally significant trees on Minjerribah (North Stradbroke Island) have persisted for up to more than 500 years
This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.